- Home
- NDRA vs SYTA Comparison
NDRA vs SYTA Comparison
Compare NDRA & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- SYTA
- Stock Information
- Founded
- NDRA 2007
- SYTA N/A
- Country
- NDRA United States
- SYTA Canada
- Employees
- NDRA N/A
- SYTA N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SYTA Telecommunications Equipment
- Sector
- NDRA Health Care
- SYTA Telecommunications
- Exchange
- NDRA Nasdaq
- SYTA Nasdaq
- Market Cap
- NDRA 3.0M
- SYTA 3.1M
- IPO Year
- NDRA 2017
- SYTA 2020
- Fundamental
- Price
- NDRA $4.33
- SYTA $3.23
- Analyst Decision
- NDRA Strong Buy
- SYTA
- Analyst Count
- NDRA 1
- SYTA 0
- Target Price
- NDRA $14,000.00
- SYTA N/A
- AVG Volume (30 Days)
- NDRA 13.9K
- SYTA 240.3K
- Earning Date
- NDRA 03-27-2025
- SYTA 04-07-2025
- Dividend Yield
- NDRA N/A
- SYTA N/A
- EPS Growth
- NDRA N/A
- SYTA N/A
- EPS
- NDRA N/A
- SYTA N/A
- Revenue
- NDRA N/A
- SYTA $11,988,979.00
- Revenue This Year
- NDRA N/A
- SYTA $75.92
- Revenue Next Year
- NDRA N/A
- SYTA $19.72
- P/E Ratio
- NDRA N/A
- SYTA N/A
- Revenue Growth
- NDRA N/A
- SYTA 41.59
- 52 Week Low
- NDRA $4.01
- SYTA $3.04
- 52 Week High
- NDRA $2,170.00
- SYTA $885.60
- Technical
- Relative Strength Index (RSI)
- NDRA 35.49
- SYTA 30.99
- Support Level
- NDRA $4.62
- SYTA $3.04
- Resistance Level
- NDRA $5.40
- SYTA $5.40
- Average True Range (ATR)
- NDRA 0.30
- SYTA 0.49
- MACD
- NDRA -0.05
- SYTA -0.06
- Stochastic Oscillator
- NDRA 0.00
- SYTA 8.05
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.